Platelet-derived growth factor reorganizes the actin cytoskeleton through 3-phosphoinositide-dependent and 3-phosphoinositide-independent mechanisms in human mesangial cells

Nephron - Physiology

Volumn 107, Issue 2, 2007, Pages

  Harper, Lisa ^a   Kashiwagi, Yasuyo ^a   Pusey, Charles D ^a   Hendry, Bruce M ^b   Domin, Jan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Actin; Cytoskeleton reorganization; Phosphoinositide 3 kinase; Platelet derived growth factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACTIN; BISINDOLYLMALEIMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; WORTMANNIN;

ADULT; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; CYTOSKELETON; DISSOLUTION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESANGIUM CELL; PRIORITY JOURNAL; STRESS FIBER; WOUND HEALING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; CELL MOVEMENT; CELLS, CULTURED; CYTOSKELETON; HUMANS; MESANGIAL CELLS; PHOSPHATIDYLINOSITOL PHOSPHATES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES;

EID: 35048842359     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107805     Document Type: Article

References (50)

1. Floege J: Glomerular remodelling: novel therapeutic approaches derived from the apparently chaotic growth factor network. Nephron 2002;91:582-587.
2. Kagami S, Urushihara M, Kitamura A, Kondo S, Hisayama T, Kitamura M, Loster K, Reutter W, Kuroda Y: PDGF-BB enhances alpha1beta1 integrin-mediated activation of the ERK/AP-1 pathway involved in collagen matrix remodeling by rat mesangial cells. J Cell Physiol 2004;198:470-478.
3. Floege J, Eitner F, van Roeyen C, Ostendorf T: PDGF-D and renal disease: yet another one of those growth factors? J Am Soc Nephrol 2003;14:2690-2691.
4. Heldin CH, Ostman A, Rönnstrand L: Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998;1378:F79-F113.
5. Hudkins KL, Gilbertson DG, Carling M, Taneda S, Hughes SD, Holdren MS, Palmer TE, Topouzis S, Haran AC, Feldhaus AL, Alpers CE: Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J Am Soc Nephrol 2004;15:286-298.
6. Eitner F, Ostendorf T, Kretzler M, Cohen CD, Eriksson U, Grone HJ, Floege J: PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. J Am Soc Nephrol 2003;14:1145-1153.
7. Kazlauskas A, Cooper JA: Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 1989;58:1121-1133.
8. Shimamura H, Terada Y, Okado T, Tanaka H, Inoshita S, Sasaki S: The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. J Am Soc Nephrol 2003;14:1427-1434.
9. Iida H, Seifert R, Alpers CE, Gronwald RG, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, Johnson RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 1991;88:6560-6564.
10. Lindahl P, Hellström M, Kalen M, Karlsson L, Pekny M, Pekna M, Soriano P, Betsholtz C: Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998;125:3313-3322.
11. Sano H, Ueda Y, Takakura N, Takemura G, Doi T, Kataoka H, Murayama T, Xu Y, Sudo T, Nishikawa S, Nishikawa S, Fujiwara H, Kita T, Yokode M: Blockade of platelet-derived growth factor receptor-beta pathway induces apoptosis of vascular endothelial cells and disrupts glomerular capillary formation in neonatal mice. Am J Pathol 2002;161:135-143.
12. Bjarnegard M, Enge M, Norlin J, Gustafsdottir S, Fredriksson S, Abramsson A, Takemoto M, Gustafsson E, Fassler R, Betsholtz C: Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004;131:1847-1857.
13. Suzuki A, Iwatani H, Ito T, Imai E, Okabe M, Nakamura H, Isaka Y, Yamato M, Hori M: Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells. Kidney Int 2004;65:15-24.
14. Ostendorf T, Kunter U, van Roeyen C, Dooley S, Janjic N, Ruckman J, Eitner F, Floege J: The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system. J Am Soc Nephrol 2002;13:658-667.
15. Rönnstrand L, Heldin CH: Mechanisms of platelet-derived growth factor-induced chemotaxis. Int J Cancer 2001;91:757-762.
16. Jaffe AB, Hall A: Cell biology. Smurfing at the leading edge. Science 2003;302:1690-1691.
17. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR: Cell migration: integrating signals from front to back. Science 2003;302:1704-1709.
18. Choudhury GG, Grandaliano G, Jin DC, Katz MS, Abboud HE: Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. Kidney Int 2000;57:908-917.
19. Crean JK, Finlay D, Murphy M, Moss C, Godson C, Martin F, Brady HR: The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 2002;277:44187-44194.
20. Nelson PJ, Moissoglu K, Vargas J Jr, Klotman PE, Gelman IH: Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. J Cell Sci 1999;112(Pt 3):361-370.
21. Gruden G, Thomas S, Burt D, Lane S, Chusney G, Sacks S, Viberti G: Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci USA 1997;94:12112-12116.
22. Blom IE, van Dijk AJ, Wieten L, Duran K, Ito Y, Kleij L, deNichilo M, Rabelink TJ, Weening JJ, Aten J, Goldschmeding R: In vitro evidence for differential involvement of CTGF, TGF-beta, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 2001;16:1139-1148.
23. Domin J, Harper L, Aubyn D, Wheeler M, Florey O, Haskard D, Yuan M, Zicha D: The class II phosphoinositide 3-kinase PI3K-C2beta regulates cell migration by a PtdIns3P dependent mechanism. J Cell Physiol 2005;205:452-462.
24. Katso RM, Pardo OE, Palamidessi A, Franz CM, Marinov M, De Laurentiis A, Downward J, Scita G, Ridley AJ, Waterfield MD, Arcaro A: Phosphoinositide 3-kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms. Mol Biol Cell 2006;17:3729-3744.
25. Prigozhina NL, Waterman-Storer CM: Decreased polarity and increased random motility in PtK1 epithelial cells correlate with inhibition of endosomal recycling. J Cell Sci 2006;119:3571-3582.
26. Barnes JL, Hevey KA: Glomerular mesangial cell migration. Response to platelet secretory products. Am J Pathol 1991;138:859-866.
27. Merlot S, Firtel RA: Leading the way: directional sensing through phosphatidylinositol 3-kinase and other signaling pathways. J Cell Sci 2003;116:3471-3478.
28. Welch HC, Coadwell WJ, Stephens LR, Hawkins PT: Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett 2003;546:93-97.
29. Cote JF, Motoyama AB, Bush JA, Vuori K: A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling. Nat Cell Biol 2005;7:797-807.
30. Tolias KF, Cantley LC, Carpenter CL: Rho family GTPases bind to phosphoinositide kinases. J Biol Chem 1995;270:17656-17659.
31. Weiner OD, Neilsen PO, Prestwich GD, Kirschner MW, Cantley LC, Bourne HR: A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat Cell Biol 2002;4:509-513.
32. Funamoto S, Meili R, Lee S, Parry L, Firtel RA: Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 2002;109:611-623.
33. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A: Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 2004;303:1179-1181.
34. Greenwood JA, Theibert AB, Prestwich GD, Murphy-Ullrich JE: Restructuring of focal adhesion plaques by PI 3-kinase. Regulation by PtdIns(3,4,5)-p(3) binding to alpha-actinin. J Cell Biol 2000;150:627-642.
35. Kruger JS, Reddy KB: Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Mol Cancer Res 2003;1:801-809.
36. Willis AI, Fuse S, Wang XJ, Chen E, Tuszynski GP, Sumpio BE, Gahtan V: Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis. J Vasc Surg 2000;31:1160-1167.
37. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE: Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension 1997;29:334-339.
38. Knall C, Worthen GS, Johnson GL: Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci USA 1997;94:3052-3057.
39. Choudhury GG, Biswas P, Grandaliano G, Fouqueray B, Harvey SA, Abboud HE: PDGF-mediated activation of phosphatidylinositol 3 kinase in human mesangial cells. Kidney Int 1994;46:37-47.
40. Campbell M, Trimble ER: Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII. Circ Res 2005;96:197-206.
41. Raftopoulou M, Hall A: Cell migration: Rho GTPases lead the way. Dev Biol 2004;265:23-32.
42. Buday L, Wunderlich L, Tamas P: The Nck family of adapter proteins: regulators of actin cytoskeleton. Cell Signal 2002;14:723-731.
43. Grimsley CM, Kinchen JM, Tosello-Trampont AC, Brugnera E, Haney LB, Lu M, Chen Q, Klingele D, Hengartner MO, Ravichandran KS: Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. J Biol Chem 2004;279:6087-6097.
44. Plevin R, Cook SJ, Palmer S, Wakelam MJ: Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth-factor-stimulated Swiss 3T3 fibroblasts. Evidence for activation of phosphoinositidase C and phosphatidylcholine-specific phospholipase D. Biochem J 1991;279(Pt 2):559-565.
45. 2. J Biol Chem 1993;268:8927-8934.
46. Susa M, Thomas G: Identical Mr 70,000 S6 kinase is activated biphasically by epidermal growth factor: a phosphopeptide that characterizes the late phase. Proc Natl Acad Sci USA 1990;87:7040-7044.
47. Wilkes MC, Murphy SJ, Garamszegi N, Leof EB: Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3. Mol Cell Biol 2003;23:8878-8889.
48. Siegel PM, Massague J: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003;3:807-821.
49. Choudhury GG, Karamitsos C, Hernandez J, Gentilini A, Bardgette J, Abboud HE: PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF. Am J Physiol 1997;273(6 Pt 2):F931-F938.
50. 2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem 1995;270:25352-25355.